Inhibitors of the n-terminal domain of the androgen receptor
US-12162818-B2 · Dec 10, 2024 · US
US10526264B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10526264-B2 |
| Application number | US-201716315417-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 23, 2017 |
| Priority date | Jul 7, 2016 |
| Publication date | Jan 7, 2020 |
| Grant date | Jan 7, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds of formula I a process for preparation of compounds of formula I; precursor compounds of formula II a process for preparation of precursor compounds of formula II; compounds of formula III a process for the preparation of compounds of formula IV from compounds of formula III and the use of compounds of formula I for the preparation of compounds of formula IV.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula I wherein R 1 is halomethyl; R 2 is halogen, halomethyl, or halomethoxy; R 3 , R 4 are independently H, or as defined for R 2 ; R 5a is H, C 1 -C 4 -alkyl, or C 1 -C 4 -haloalkyl; R 5b is CN, halogen, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, C 1 -C 2 -alkoxy, C 1 -C 2 -haloalkoxy; or R 5a and R 5b form together with the C-atoms they are bound to a 5-, or 6-membered saturated, partially, or fully unsaturated ring containing none, or one heteroatom O, N(O) n or S(O) m as ring members; A is halogen, CN, C 1 -C 6 -alkoxy, C 6 -C 10 -aryloxy, C 1 -C 6 -haloalkoxy, C 6 -C 10 -arylalkoxy, C 6 -C 10 -aryl-C 1 -C 6 -alkoxy, OS(O) 2 R 6 ; or a group A 1 , or A 2 ; wherein A 1 is a group of following formula: wherein # denotes the attachment point to the remainder of the molecule; Y OR 7 , or N(R 8 )R 9 ; and A 2 is a group of following formula: wherein # denotes the attachment point to the remainder of the molecule; R 6 halogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl; phenyl, which is unsubstituted, or substituted by halogen, OH, CN, NO 2 , C 1 -C 6 -alkyl, or C 1 -C 6 -haloalkyl; R 7 a) H; b) C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkenyl, C 1 -C 6 -alkynyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl; or c) phenyl, or benzyl, which are unsubstituted, or substituted by halogen, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, or C 1 -C 2 -alkoxy; R 8 H, CN; C 1 -C 6 -alkyl-C(═O), C 1 -C 6 -haloalkyl-C(═O), C 1 -C 6 -alkyl-OC(═O), C 1 -C 6 -alkenyl-OC(═O), or C 6 -C 12 -aryl-C 1 -C 6 -alkyl-OC(═O); C 1 -C 10 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkynyl, which are unsubstituted or substituted by R 81 ; R 81 halogen, CN, N 3 , NO 2 , SCN, SF 5 , C 3 -C 8 -cycloalkyl, C 3 -C 8 halocycloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 3 -C 8 -cycloalkoxy, or C 3 -C 8 -halocycloalkoxy; R 9 H; C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, which are unsubstituted, or substituted by R 91 ; C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, which are unsubstituted, or substituted by R 92 ; N(R 93 )R 94 ; phenyl, heterocyclyl, or hetaryl, which are unsubstituted, or substituted by R D ; or C 1 -C 6 -alkyl-C(═O), C 1 -C 6 -haloalkyl-C(═O), C 1 -C 6 -alkyl-OC(═O), C 1 -C 6 -alkenyl-OC(═O), or C 6 -C 12 -aryl-C 1 -C 6 -alkyl-OC(═O); R 91 halogen, OH, CN, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkyl-S(O) m , C 1 -C 4 -haloalkyl-S(O) m , C(═O)N(R A )R B ; C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, which are unsubstituted, or substituted by R C ; phenyl, heterocyclyl, or hetaryl which are unsubstituted, or substituted by R D ; R A , R 93 H, C 1 -C 3 -alkyl, or C 1 -C 3 -haloalkyl; R B H, C 1 -C 3 -alkyl, C 1 -C 3 -haloalkyl, C 2 -C 3 -alkenyl, C 2 -C 3 -haloalkenyl, C 2 -C 3 -alkynyl, C 2 -C 3 -haloalkynyl, C 1 -C 3 -alkoxy, C 1 -C 3 -haloalkoxy, C 3 -C 4 -halocycloalkyl; or C 3 -C 4 -cycloalkyl, C 3 -C 4 -halocycloalkyl, C 3 -C 4 -cycloalkylmethyl, C 3 -C 4 -halocycloalkylmethyl, wherein the cyclic groups are unsubstituted, or substituted by CN; R C OH, CN, C 1 -C 2 -alkyl, or C 1 -C 2 -haloalkyl; R D halogen, CN, NO 2 , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -haloalkenyl, C 2 -C 4 -alkynyl, C 2 -C 4 -haloalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, C 3 -C 4 -cycloalkylmethyl, or C 3 -C 4 -halocycloalkylmethyl; or two R D present on the same carbon atom of a saturated, or partially saturated ring form together a carbonyl group (═O); R 92 C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, or a group as defined for R 91 ; R 94 C(═O)N(R A )R B , C(═O)OR A ; or phenyl, heterocyclyl, or hetaryl which rings are unsubstituted, or substituted by R D ; R 10 H, CN, methyl, or halomethyl; R 11 H, C 1 -C 6 -alkyl-C(═O), C 1 -C 6 -haloalkyl-C(═O), C 1 -C 6 -alkyl-OC(═O), C 1 -C 6 -alkenyl-OC(═O), or C 6 -C 12 -aryl-C 1 -C 6 -alkyl-OC(═O); R 12 H, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, which are unsubstituted, or substituted by R 91 ; C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, which are unsubstituted, or substituted by R 92 ; or phenyl, heterocycyl, or hetaryl which rings are unsubstituted, or substituted by R D ; n is 0, or 1; m is 0, 1, or 2; and the N-oxides, stereoisomers and agriculturally or veterinarily acceptable salts thereof. 2. The compound of claim 1 , wherein R 1 is CF 3 ; R 2 is F, Cl, Br, CF 3 , or OCF 3 ; R 3 , R 4 are independently H, or as defined for R 2 ; R 5a is H; and R 5b is F, Cl, Br, CH 3 , or CF 3 ; or R 5a and R 5b form together with the C-atoms they are bound to a bridging group selected from —CH═CH—CH═CH—, —CH═CH—CH═N—, —CH═CH—N═CH—, —CH═N—CH═CH—, —N═CH—CH═CH—, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, —CH 2 CH 2 O—, —OCH 2 CH 2 —, —CH 2 CH 2 CH 2 O—, —OCH 2 CH 2 CH 2 —, —CH 2 CH 2 S(O) p —, —S(O) p CH 2 CH 2 —; and wherein p is 0, 1, or 2. 3. The compound of claim 1 , wherein A is A 1 ; Y is OR 7 ; and R 7 is as defined in claim 1 . 4. The compound of claim 3 , wherein R 7 is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkenyl, C 1 -C 6 -alkynyl, phenyl, or benzyl. 5. The compound of claim 2 , wherein A is A 1 ; Y is N(H)R 9 . 6. The compound of claim 1 , wherein A is Cl, Br, I, or CN. 7. The compound of claim 1 , wherein A is A 2 ; R 10 H; and R 12 C 1 -C 4 -alkyl, and C 1 -C 4 -haloalkyl, which are unsubstituted, or substituted by R 91 ; C 3 -C 5 -cycloalkyl, C 3 -C 5 -halocycloalkyl, which are unsubstituted, or substituted by R 92 ; R 91 is independently OH, CN, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkyl-S(O) m , C 1 -C 4 -haloalkyl-S(O) m ; C 3 -C 5 -cycloalkyl, C 3 -C 5 -halocycloalkyl, which are unsubstituted, or substituted by R C ; R C is independently OH, CN, C 1 -C 2 -alkyl, or C 1 -C 2 -haloalkyl; R 92 is independently C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, or a group as defined for R 91 ; and m is 0, 1, or 2. 8. A process for preparing the compound of claim 1 comprising reacting a compound of formula II with a base at a temperature from −100 to 50° C., followed by rearrangement at a temperature from −50 to 150° C. 9. The process of claim 8 , wherein the reaction of the compound of formula (II) with the base is carried out in a solvent selected from the selected from an aliphatic C 5 -C 16 -hydrocarbon, aromatic C 6 -C 10 -hydrocarbon, halogenated aliphatic C 1 -C 6 -hydrocarbon, halogenated aromatic C 6 -C 10 -hydrocarbon, a C 1 -C 6 -cycloalkyl ether, a C 1 -C 6 -alkyl-C 1 -C 6 -alkyl ether, and a C 1 -C 6 -alkyl-C 6 -C 10 -aryl ether, or a mixture thereof. 10. The process of claim 8 , wherein the rearrangement is carried out at a temperature from −10 to 40° C. 11. The process of claim 8 , wherein compound of formula I are subsequently reacted with an olefinating agent to compound of formula III wherein all substituents have
by increase in the number of carbon atoms · CPC title
Polycyclic · CPC title
Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring · CPC title
having unsaturation outside the aromatic rings · CPC title
polycyclic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.